Matthew J. Wyvratt

7.2k total citations
116 papers, 3.9k citations indexed

About

Matthew J. Wyvratt is a scholar working on Molecular Biology, Organic Chemistry and Animal Science and Zoology. According to data from OpenAlex, Matthew J. Wyvratt has authored 116 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 45 papers in Organic Chemistry and 23 papers in Animal Science and Zoology. Recurrent topics in Matthew J. Wyvratt's work include Growth Hormone and Insulin-like Growth Factors (18 papers), Receptor Mechanisms and Signaling (16 papers) and Synthesis and Biological Evaluation (14 papers). Matthew J. Wyvratt is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (18 papers), Receptor Mechanisms and Signaling (16 papers) and Synthesis and Biological Evaluation (14 papers). Matthew J. Wyvratt collaborates with scholars based in United States, Germany and Japan. Matthew J. Wyvratt's co-authors include Michael H. Fisher, Arthur A. Patchett, Roy G. Smith, Gerard J. Hickey, Kang Cheng, Mark T. Goulet, Leo A. Paquette, Robert J. DeVita, William R. Schoen and M. H. Fisher and has published in prestigious journals such as Science, Journal of the American Chemical Society and The Journal of Experimental Medicine.

In The Last Decade

Matthew J. Wyvratt

115 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew J. Wyvratt United States 34 1.6k 1.5k 724 717 547 116 3.9k
Arthur A. Patchett United States 39 3.5k 2.2× 1.4k 1.0× 1.1k 1.5× 924 1.3× 679 1.2× 126 6.7k
Paolo Grieco Italy 38 2.1k 1.3× 934 0.6× 660 0.9× 369 0.5× 212 0.4× 207 4.6k
Jean‐Luc Boucher France 34 1.2k 0.8× 598 0.4× 224 0.3× 124 0.2× 1.6k 2.9× 115 4.4k
Gerald W. Becker United States 30 1.6k 1.0× 242 0.2× 537 0.7× 240 0.3× 658 1.2× 53 4.0k
Matthias U. Kassack Germany 48 2.9k 1.8× 1.1k 0.8× 198 0.3× 278 0.4× 226 0.4× 153 5.5k
Erich Wünsch Germany 31 2.2k 1.4× 965 0.7× 98 0.1× 284 0.4× 271 0.5× 167 3.6k
Charles A. Nichol United States 34 2.0k 1.3× 587 0.4× 72 0.1× 218 0.3× 633 1.2× 113 4.2k
Bernard Rubin United States 24 2.0k 1.3× 219 0.2× 72 0.1× 391 0.5× 326 0.6× 63 3.6k
Judith Storch United States 50 4.1k 2.6× 272 0.2× 79 0.1× 443 0.6× 1.4k 2.5× 124 6.6k
Peter T. Meinke United States 33 2.2k 1.4× 904 0.6× 45 0.1× 281 0.4× 341 0.6× 108 4.2k

Countries citing papers authored by Matthew J. Wyvratt

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Wyvratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Wyvratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Wyvratt more than expected).

Fields of papers citing papers by Matthew J. Wyvratt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Wyvratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Wyvratt. The network helps show where Matthew J. Wyvratt may publish in the future.

Co-authorship network of co-authors of Matthew J. Wyvratt

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Wyvratt. A scholar is included among the top collaborators of Matthew J. Wyvratt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Wyvratt. Matthew J. Wyvratt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Gui‐Bai, Xiaoxia Qian, Dennis Feng, et al.. (2008). N-Alkyl-4-piperidinyl-2,3-diarylpyrrole derivatives with heterocyclic substitutions as potent and broad spectrum anticoccidial agents. Bioorganic & Medicinal Chemistry Letters. 18(6). 2019–2022. 14 indexed citations
2.
Hoyt, Scott B., Clare London, Matthew J. Wyvratt, et al.. (2008). 3-Amino-1,5-benzodiazepinones: Potent, state-dependent sodium channel blockers with anti-epileptic activity. Bioorganic & Medicinal Chemistry Letters. 18(6). 1963–1966. 5 indexed citations
3.
Dennis, Richard, Shuliang Lee, Gilles Ouvry, et al.. (2007). Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II. European Journal of Medicinal Chemistry. 43(6). 1123–1151. 35 indexed citations
4.
Dennis, Richard, Shuliang Lee, David A. Perrey, et al.. (2007). Synthesis and biological activity of imidazopyridine anticoccidial agents: Part I. European Journal of Medicinal Chemistry. 42(11-12). 1334–1357. 45 indexed citations
5.
Patchett, Arthur A., Roy G. Smith, & Matthew J. Wyvratt. (2006). Orally Active Growth Hormone Secretagogues. Kluwer Academic Publishers eBooks. 11. 525–554. 1 indexed citations
6.
Li, Chunshi, Catherine Abbadie, John P. Felix, et al.. (2005). Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers. Bioorganic & Medicinal Chemistry Letters. 16(5). 1358–1361. 9 indexed citations
7.
Ye, Zhixiong, Tanya MacNeil, David H. Weinberg, et al.. (2005). Structure–activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in rat. Peptides. 26(10). 2017–2025. 8 indexed citations
8.
Liang, Gui‐Bai, Xiaoxia Qian, Tesfaye Biftu, et al.. (2005). Hydroxylated N-alkyl-4-piperidinyl-2,3-diarylpyrrole derivatives as potent broad-spectrum anticoccidial agents. Bioorganic & Medicinal Chemistry Letters. 15(20). 4570–4573. 11 indexed citations
9.
Jiang, Jinlong, Robert J. DeVita, Mark T. Goulet, et al.. (2004). Syntheses and structure–activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists. Bioorganic & Medicinal Chemistry Letters. 14(7). 1795–1798. 18 indexed citations
10.
Edmondson, Scott D., Anthony Mastracchio, Jiafang He, et al.. (2003). Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 3983–3987. 28 indexed citations
11.
Li, Chunshi, Thomas L. Shih, Steven L. Colletti, et al.. (2002). Side-chain homologation of nodulisporic acid: synthesis of potent new dienyl derivatives. Bioorganic & Medicinal Chemistry Letters. 12(13). 1751–1754. 8 indexed citations
12.
Biftu, Tesfaye, Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1427–1429. 15 indexed citations
13.
Parmee, Emma R., Linda Brockunier, Jiafang He, et al.. (2000). Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2283–2286. 12 indexed citations
14.
Meinke, Peter T., Steven L. Colletti, Sandra J. Darkin‐Rattray, et al.. (2000). Synthesis of side chain modified apicidin derivatives: potent mechanism-based histone deacetylase inhibitors. Tetrahedron Letters. 41(41). 7831–7835. 25 indexed citations
15.
Forrest, Michael J., Gary J. Hom, Mari R. Candelore, et al.. (2000). L-750355, a human ß3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey. European Journal of Pharmacology. 407(1-2). 175–181. 8 indexed citations
16.
DeVita, Robert J., Mark T. Goulet, Matthew J. Wyvratt, et al.. (1999). Investigation of the 4-O-alkylamine substituent of non-peptide quinolone GnRH receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(17). 2621–2624. 43 indexed citations
17.
Peterson, Laurence B., John G. Cryan, Ray Rosa, et al.. (1998). A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH BIOCHEMICAL PROPERTIES DISTINCT FROM THOSE OF TACROLIMUS. Transplantation. 65(1). 10–18. 21 indexed citations
18.
Dumont, Francis J., Mary Jo Staruch, Gloria C. Koo, et al.. (1998). A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH REDUCED TOXICITY. Transplantation. 65(1). 18–26. 23 indexed citations
19.
DeVita, Robert J., William R. Schoen, G. A. Doldouras, et al.. (1995). Heterocyclic analogs of the benzolactam nucleus of the non-peptidic growth hormone secretagogue L-692,429. Bioorganic & Medicinal Chemistry Letters. 5(12). 1281–1286. 9 indexed citations
20.
Dumont, Francis J., Mary Jo Staruch, Sam L. Koprak, et al.. (1992). The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.. The Journal of Experimental Medicine. 176(3). 751–760. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026